TransMedics Group, Inc. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
TransMedics Group, Inc. (TMDX) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $763.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-08-04
- TransMedics Group, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-06-30 was $450.00K.
- TransMedics Group, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-03-31 was $313.00K.
- TransMedics Group, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-12-31 was $0.00.
- TransMedics Group, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-09-30 was $471.00K.
- TransMedics Group, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $795.00K, a 46.96% decline from fiscal 2024.
- TransMedics Group, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $1.50M, a 30.95% decline from fiscal 2023.
- TransMedics Group, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $2.17M.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | $450.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $763.00K 10-Q · filed 2026-08-04 | $763.00K derived: sum of 3 quarters · filed 2026-08-04 | $1.23M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $313.00K 10-Q · filed 2026-05-05 | $313.00K derived: sum of 2 quarters · filed 2026-05-05 | $784.00K derived: sum of 3 quarters · filed 2026-05-05 | |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $471.00K derived: sum of 2 quarters · filed 2026-02-24 | $795.00K 10-K · filed 2026-02-24 | |
| 2025-09-30 | $471.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $795.00K 10-Q · filed 2025-10-29 | ||
| 2025-06-30 | $324.00K 10-Q · filed 2026-08-04 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.50M 10-K · filed 2026-02-24 | ||
| 2024-09-30 | $1.50M 10-Q · filed 2025-10-29 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$51.00K derived: sum of 2 quarters · filed 2026-02-24 | $2.17M 10-K · filed 2026-02-24 | |
| 2023-09-30 | -$51.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $2.17M 10-Q · filed 2024-10-29 | ||
| 2023-06-30 | $2.22M 10-Q · filed 2024-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |